Skip to main
GLYC
GLYC logo

GlycoMimetics (GLYC)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy GlycoMimetics (GLYC) Stock

About GlycoMimetics (GLYC)

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.
Market cap$195.75M
Today's volume76.05K
Revenue (TTM)
Avg. daily volume143.02K
EBITDA (TTM)-$54.6M
Open$14.27
Price / earnings ratio-0.64x
Today's range$12.98 - $14.27
Debt / equity1.49x
52 week range$9.81 - $37
5 year debt / equity0.56x
Beta (LTM)1.3x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio6.63x
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

As of Dec 14, 2025, the market cap for GLYC stock is $195.75M

The current P/E ratio for GLYC stock is -0.64

The 52-week high for GLYC stock is $37. The current GLYC stock price $undefined is 100.00% below its 52-week high

The 52-week low for GLYC stock is $9.81. The current GLYC stock price $undefined has increased 100.00% from its 52-week low

No, the GLYC stock does not pay dividends to its shareholders

How to buy GLYC stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in GLYC stock

    Navigate to the Explore page. Then, type GLYC into the search bar. When you see GLYC stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased GLYC stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

GlycoMimetics Stock Earnings

The value each GLYC share was expected to gain vs. the value that each GLYC share actually gained.

GlycoMimetics (GLYC) reported Q4 2024 earnings per share (EPS) of -$11, missing estimates of -$7 by 57.14%. In the same quarter last year, GlycoMimetics's earnings per share (EPS) was -$14. GlycoMimetics is expected to release next earnings on , with an earnings per share (EPS) estimate of $0.

Buy GlycoMimetics (GLYC) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.